Wealth Enhancement Advisory Services LLC boosted its stake in GSK plc (NYSE:GSK – Free Report) by 5.7% in the second quarter, according to its most recent Form 13F filing with the Securities & ...
EP Wealth Advisors LLC lessened its stake in shares of GSK plc (NYSE:GSK – Free Report) by 26.9% during the 2nd quarter, HoldingsChannel.com reports. The institutional investor owned 10,115 shares of ...
Wondering if GSK is actually undervalued or if there's more to the story than recent headlines suggest? You're not alone, and we're about to dive into what those numbers really mean. Despite a slight ...
GSK plc stock (NYSE: GSK) trades at $38 per share, about 20% below its peak level of over $47 seen in April 2022. In contrast, its peer Bristol Myers Squibb stock (NYSE: BMY) saw a 48% decline over ...
The most recent trading session ended with GSK (GSK) standing at $42.32, reflecting a +0.43% shift from the previouse trading day's closing. The stock trailed the S&P 500, which registered a daily ...
GSK (GSK) ended the recent trading session at $39.53, demonstrating a -0.38% swing from the preceding day's closing price. The stock fell short of the S&P 500, which registered a gain of 0.22% for the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results